Published on 17 Jul 2023 on Benzinga via Yahoo Finance
Novan Inc (NASDAQ: NOVN) shares are trading lower after Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has offered to acquire the company's assets.
The deal value includes $15 million in cash and provides up to $15 million in DIP financing to Novan, including a $3 million bridge loan already funded.
* Right now, we’re issuing “Double... Express is an advertising partner of Motley Fool Money. Bra...
Novartis AG NVS, a Swiss pharma giant, is scheduled to report fourth-quarter 2024 and full-year...
Plus, we'll get the personal income and spending report, which includes the Fed's preferred measu...
Swiss luxury conglomerate Richemont’s stock market value surpassed 100 billion Swiss francs ($110...
(Bloomberg) -- Donald Trump opened his second term as US president with a market-jolting...
(Bloomberg) -- Donald Trump opened his second term as US president with a market-jolting...
Its top 10 holdings account for approximately 16.12% of IQDF's total assets under management....
ONS-5010 demonstrated non-inferiority to Novartis AG (NYSE:NVS) / Roche Holdings AG’s (OTC:RHHBY)...
We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this...
The South San Francisco company (Nasdaq: RAPT) also said it lined up $150 million from a...
Copyright Statfolio @ 2025